| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 3.42e-05 | 9 | 20 | 2 | GO:0003810 | |
| GeneOntologyMolecularFunction | methyl-CpG binding | 4.36e-04 | 31 | 20 | 2 | GO:0008327 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 3.44e-06 | 31 | 20 | 3 | GO:0071295 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient | 1.98e-05 | 55 | 20 | 3 | GO:0031670 | |
| GeneOntologyBiologicalProcess | response to vitamin | 1.19e-04 | 100 | 20 | 3 | GO:0033273 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | 1.68e-04 | 566 | 20 | 5 | GO:0031667 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 2.23e-04 | 23 | 20 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | response to estradiol | 2.46e-04 | 128 | 20 | 3 | GO:0032355 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 3.09e-04 | 27 | 20 | 2 | GO:0018149 | |
| Domain | - | 3.04e-05 | 8 | 20 | 2 | 3.30.890.10 | |
| Domain | Transglut_N | 3.90e-05 | 9 | 20 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 3.90e-05 | 9 | 20 | 2 | PS00547 | |
| Domain | Transglutaminase_N | 3.90e-05 | 9 | 20 | 2 | IPR001102 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 3.90e-05 | 9 | 20 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 3.90e-05 | 9 | 20 | 2 | IPR013808 | |
| Domain | Transglut_C | 3.90e-05 | 9 | 20 | 2 | PF00927 | |
| Domain | - | 3.90e-05 | 9 | 20 | 2 | 3.90.260.10 | |
| Domain | Transglutaminase_C | 4.88e-05 | 10 | 20 | 2 | IPR008958 | |
| Domain | TGc | 5.96e-05 | 11 | 20 | 2 | SM00460 | |
| Domain | Transglut_core | 5.96e-05 | 11 | 20 | 2 | PF01841 | |
| Domain | Methyl_CpG_DNA-bd | 5.96e-05 | 11 | 20 | 2 | IPR001739 | |
| Domain | MBD | 5.96e-05 | 11 | 20 | 2 | PF01429 | |
| Domain | Transglutaminase-like | 5.96e-05 | 11 | 20 | 2 | IPR002931 | |
| Domain | MBD | 5.96e-05 | 11 | 20 | 2 | SM00391 | |
| Domain | MBD | 5.96e-05 | 11 | 20 | 2 | PS50982 | |
| Domain | DNA-bd_dom | 5.96e-05 | 11 | 20 | 2 | IPR016177 | |
| Domain | LAM_G_DOMAIN | 7.48e-04 | 38 | 20 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 8.29e-04 | 40 | 20 | 2 | PF02210 | |
| Domain | LamG | 1.00e-03 | 44 | 20 | 2 | SM00282 | |
| Domain | Laminin_G | 1.74e-03 | 58 | 20 | 2 | IPR001791 | |
| Domain | - | 4.58e-03 | 95 | 20 | 2 | 2.60.120.200 | |
| Domain | ASX_HYDROXYL | 5.06e-03 | 100 | 20 | 2 | PS00010 | |
| Domain | Ig_E-set | 5.47e-03 | 104 | 20 | 2 | IPR014756 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.67e-03 | 106 | 20 | 2 | IPR000152 | |
| Domain | EGF_CA | 7.45e-03 | 122 | 20 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.68e-03 | 124 | 20 | 2 | IPR001881 | |
| Domain | EGF | 7.92e-03 | 126 | 20 | 2 | PF00008 | |
| Domain | ConA-like_dom | 2.26e-02 | 219 | 20 | 2 | IPR013320 | |
| Domain | EGF | 2.58e-02 | 235 | 20 | 2 | SM00181 | |
| Domain | EGF_3 | 2.58e-02 | 235 | 20 | 2 | PS50026 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 23896968 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 22080209 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 20876521 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 29743665 | ||
| Pubmed | Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. | 3.14e-07 | 2 | 20 | 2 | 17762854 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 18673368 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 22573678 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 8626785 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 24885370 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11113189 | ||
| Pubmed | Expression of Transglutaminase in Foreskin of Children with Balanitis Xerotica Obliterans. | 9.42e-07 | 3 | 20 | 2 | 27649154 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 31786225 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 24849540 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 19781662 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 14610093 | ||
| Pubmed | Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. | 9.42e-07 | 3 | 20 | 2 | 15715085 | |
| Pubmed | Transglutaminase and clusterin induction during normal and abnormal limb development in the mouse. | 1.88e-06 | 4 | 20 | 2 | 8828830 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 20080707 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 16465267 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 9511731 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 9448282 | ||
| Pubmed | Identification and characterization of a family of mammalian methyl-CpG binding proteins. | 3.14e-06 | 5 | 20 | 2 | 9774669 | |
| Pubmed | Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. | 3.14e-06 | 5 | 20 | 2 | 11371345 | |
| Pubmed | Identification of imprinting regulators at the Meg3 differentially methylated region. | 3.14e-06 | 5 | 20 | 2 | 22709555 | |
| Pubmed | Characterization of TG2 and TG1-TG2 double knock-out mouse epidermis. | 3.14e-06 | 5 | 20 | 2 | 27864691 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 17546630 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 22258055 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 9878253 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 11390390 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 7906657 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 24653733 | ||
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 7688299 | ||
| Pubmed | Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. | 2.44e-05 | 13 | 20 | 2 | 10441743 | |
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 12124384 | ||
| Pubmed | Single cell RT-PCR on mouse embryos: a general approach for developmental biology. | 2.44e-05 | 13 | 20 | 2 | 20300987 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 18784354 | ||
| Pubmed | The transcription factor Otx2 regulates choroid plexus development and function. | 1.64e-04 | 33 | 20 | 2 | 23364326 | |
| Pubmed | 2.92e-04 | 228 | 20 | 3 | 30471916 | ||
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 4.58e-04 | 55 | 20 | 2 | 32561725 | |
| Pubmed | 4.75e-04 | 56 | 20 | 2 | 35918402 | ||
| GeneFamily | Transglutaminases | 2.63e-05 | 9 | 16 | 2 | 773 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 4.02e-05 | 11 | 16 | 2 | 1025 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 194 | 20 | 4 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-06 | 196 | 20 | 4 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-06 | 196 | 20 | 4 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-06 | 199 | 20 | 4 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-06 | 199 | 20 | 4 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.74e-06 | 200 | 20 | 4 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.74e-06 | 200 | 20 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-06 | 200 | 20 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-06 | 200 | 20 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 5.47e-05 | 167 | 20 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.56e-05 | 168 | 20 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.07e-05 | 173 | 20 | 3 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.07e-05 | 173 | 20 | 3 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-05 | 174 | 20 | 3 | d81a5e767e8882ebca4678af881c94c062f8cea5 | |
| ToppCell | droplet-Heart-4Chambers-21m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 174 | 20 | 3 | f098778ea74012861ec74b425e45776a31f67679 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 178 | 20 | 3 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.61e-05 | 178 | 20 | 3 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.72e-05 | 179 | 20 | 3 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.72e-05 | 179 | 20 | 3 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-05 | 179 | 20 | 3 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.83e-05 | 180 | 20 | 3 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.83e-05 | 180 | 20 | 3 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 6.83e-05 | 180 | 20 | 3 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 6.94e-05 | 181 | 20 | 3 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 7.06e-05 | 182 | 20 | 3 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 7.17e-05 | 183 | 20 | 3 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.65e-05 | 187 | 20 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 7.77e-05 | 188 | 20 | 3 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-05 | 188 | 20 | 3 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-05 | 188 | 20 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.89e-05 | 189 | 20 | 3 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 191 | 20 | 3 | 8b34e06c398056e857a10c7653c70c0b1f181692 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-05 | 191 | 20 | 3 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-05 | 191 | 20 | 3 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 8.27e-05 | 192 | 20 | 3 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 192 | 20 | 3 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.27e-05 | 192 | 20 | 3 | a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890 | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 8.27e-05 | 192 | 20 | 3 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.27e-05 | 192 | 20 | 3 | 2c69f3f388b69fb1c1968c923cdbab90658883dd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.27e-05 | 192 | 20 | 3 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.27e-05 | 192 | 20 | 3 | d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-05 | 193 | 20 | 3 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | PBMC-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 8.40e-05 | 193 | 20 | 3 | 53ddee444dcfb9fe568e9e8fb64bc8304c262530 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-05 | 193 | 20 | 3 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-05 | 193 | 20 | 3 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 194 | 20 | 3 | 8f19e553f18c313c2a2ff9453884b9484b255d71 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 194 | 20 | 3 | f95935153bd2c4c3c7b2b729da6f7e98b45fed79 | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.53e-05 | 194 | 20 | 3 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 8.53e-05 | 194 | 20 | 3 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.53e-05 | 194 | 20 | 3 | 67fbb81b7d20cb63be27b2a2beea5b5689f8e08c | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 8.66e-05 | 195 | 20 | 3 | b748cb15846345363e8c2ee5936bb42bba3ba9a7 | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.66e-05 | 195 | 20 | 3 | 9e5cf33b5dd455efa464a63d7116786c0786aefd | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.66e-05 | 195 | 20 | 3 | 6ba23e19801305e071b0e4aaf1ee6f53f3b027d3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 195 | 20 | 3 | c771ac1db8bd5f3a80bd3484094a58c28983f97b | |
| ToppCell | Mild_COVID-19-Myeloid-cDC|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.66e-05 | 195 | 20 | 3 | 24149bb6933135b1a0a5c7f505914942b3782c3a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.66e-05 | 195 | 20 | 3 | 66e5fd9f3208a06d617c5e994822bf57dceae7e2 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.66e-05 | 195 | 20 | 3 | 7209babdff96c93cd52cfe5d5cfd7e3c0274d8dd | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-05 | 196 | 20 | 3 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | ILEUM-non-inflamed-(8)_Pericytes|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.79e-05 | 196 | 20 | 3 | b98fe1519e420d8b03c66e164bf4544f3dbb2e44 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.79e-05 | 196 | 20 | 3 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.92e-05 | 197 | 20 | 3 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.92e-05 | 197 | 20 | 3 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-05 | 197 | 20 | 3 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 198 | 20 | 3 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-05 | 199 | 20 | 3 | f4ab29f99ce45a3044d2e9f356dc24d3c5e7121f | |
| ToppCell | distal-mesenchymal-Pericyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.19e-05 | 199 | 20 | 3 | e72ac7a00405cde06293d7adac7dc40eb0cf87ba | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-05 | 199 | 20 | 3 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | medial-mesenchymal-Pericyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | bbda454260016be92b539e220ecf7bcbbc6139e4 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.33e-05 | 200 | 20 | 3 | 43b76e382b38b9856c07557a75e5b1ce0cee1d9e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | 390C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.33e-05 | 200 | 20 | 3 | 3935b6ff3ae32d170a268538c756ee34ed2308d4 | |
| ToppCell | medial-mesenchymal-Pericyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | f36d7cb6345daccebf76997f998e35d959b59452 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | ff205afda57b9267016f0c937445da1b0266af9b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.33e-05 | 200 | 20 | 3 | 78e9a40153d7ba5d9ea6393a37d26fc5c0220867 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.33e-05 | 200 | 20 | 3 | c46e06b4f22d3456e67bc62a9ac198e8041965ad | |
| ToppCell | medial-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.33e-05 | 200 | 20 | 3 | 9820fb4f6efcdfc6de937ef2302a98b48426baa3 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Gfra1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 58 | 20 | 2 | a58f4ee94896c1f790335245163179f52705fae7 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Gfra1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Gfra1_(Interneuron,_Basket_1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 58 | 20 | 2 | f058992ac3c6c3bd56ff0d1e0c9de1d61e15b387 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Gfra1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Gfra1_(Interneuron,_Basket_1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 58 | 20 | 2 | f9971c7e50844116d831be1c47fce1d213ac7228 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-Rorb_(Nucleus_of_the_lateral_olfactory_tract_(LOT))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.20e-04 | 68 | 20 | 2 | 6945089858778301a05ecc5895310d768768758c | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-Rorb_(Nucleus_of_the_lateral_olfactory_tract_(LOT))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.20e-04 | 68 | 20 | 2 | ac9d0f473c878b96a422bbdd7088eb8125574dde | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.10e-04 | 82 | 20 | 2 | 51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.34e-04 | 90 | 20 | 2 | d809ebc50917aaf13e693b21c8faa399103e7abe | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.34e-04 | 90 | 20 | 2 | 6b94b1b05d45ecdc2ac9d5445d244dac96d60c22 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.87e-04 | 99 | 20 | 2 | 8aab2a6989d342af387bd0823f79e7b326a12430 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-04 | 104 | 20 | 2 | 060f0baca239ab89c18be40c1aa31931f4791b62 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Fos_(Mural.Rgs5Acta2.Fos)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.97e-04 | 105 | 20 | 2 | 73639bfa677c7bb9e5166aa09eabaf1b05bb89a0 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Fos_(Mural.Rgs5Acta2.Fos)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.97e-04 | 105 | 20 | 2 | 84b639eb44f71d1e12bb7850b9063d80e73cb741 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 107 | 20 | 2 | 0b45241cc52d10225966b49941efb66997184158 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 107 | 20 | 2 | 2f84089acc794b43ee59452dc8f90ca7261ebd41 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.30e-03 | 120 | 20 | 2 | a320799ab5f2ce872e038b15841a23174c5436e8 | |
| Drug | Ch 80 | 7.33e-07 | 2 | 20 | 2 | ctd:C098137 | |
| Drug | Vitamin K | 4.06e-06 | 36 | 20 | 3 | ctd:D014812 | |
| Drug | suosan | 4.39e-06 | 4 | 20 | 2 | CID000008803 | |
| Drug | rifampicin | 5.58e-06 | 306 | 20 | 5 | CID005381226 | |
| Drug | Z-Gln-Gly | 7.32e-06 | 5 | 20 | 2 | CID000302424 | |
| Drug | alitame | 1.54e-05 | 7 | 20 | 2 | CID000064763 | |
| Drug | coumarin 7 | 1.54e-05 | 7 | 20 | 2 | CID000094381 | |
| Drug | CTK3D1047 | 1.73e-05 | 58 | 20 | 3 | CID013293130 | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 2.05e-05 | 8 | 20 | 2 | ctd:C064545 | |
| Drug | didansylcadaverine | 2.05e-05 | 8 | 20 | 2 | CID000108731 | |
| Drug | n-propylacrylamide | 2.05e-05 | 8 | 20 | 2 | CID000114794 | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 2.05e-05 | 190 | 20 | 4 | 970_UP | |
| Drug | WY-14643; Up 200; 100uM; MCF7; HG-U133A | 2.27e-05 | 195 | 20 | 4 | 368_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.32e-05 | 196 | 20 | 4 | 6273_DN | |
| Drug | chrysamine | 2.33e-05 | 64 | 20 | 3 | CID006011258 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.36e-05 | 197 | 20 | 4 | 6619_UP | |
| Drug | troglitazone; Down 200; 10uM; SKMEL5; HG-U133A | 2.41e-05 | 198 | 20 | 4 | 504_DN | |
| Drug | DGM-2 | 2.63e-05 | 9 | 20 | 2 | CID000016891 | |
| Drug | radicicol | 2.66e-05 | 203 | 20 | 4 | CID000005033 | |
| Drug | 3,5-di-tert-butylchalcone 4'-carboxylic acid | 3.28e-05 | 10 | 20 | 2 | ctd:C054189 | |
| Drug | AC1L1FHZ | 3.33e-05 | 215 | 20 | 4 | CID000003244 | |
| Drug | dapsone | 3.47e-05 | 73 | 20 | 3 | CID000002955 | |
| Drug | guanidinium-phosphate | 4.01e-05 | 11 | 20 | 2 | CID000160593 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 4.01e-05 | 11 | 20 | 2 | CID003035524 | |
| Drug | AC1L97MU | 4.07e-05 | 77 | 20 | 3 | CID000414413 | |
| Drug | terbutryn | 4.56e-05 | 80 | 20 | 3 | CID000013450 | |
| Drug | Tg 5 | 4.81e-05 | 12 | 20 | 2 | CID000205491 | |
| Drug | gossypol | 5.71e-05 | 247 | 20 | 4 | CID000003503 | |
| Drug | 5-(biotinamido)pentylamine | 6.63e-05 | 14 | 20 | 2 | CID000083906 | |
| Drug | cyclopropylmethyl | 9.89e-05 | 17 | 20 | 2 | CID000080245 | |
| Drug | monodansylthiacadaverine | 9.89e-05 | 17 | 20 | 2 | CID000162694 | |
| Drug | phenylacetylene | 1.38e-04 | 20 | 20 | 2 | CID000010821 | |
| Drug | Cymarigenen | 1.38e-04 | 20 | 20 | 2 | CID000005303 | |
| Drug | phloroglucinol | 1.52e-04 | 21 | 20 | 2 | CID000000359 | |
| Drug | Npys | 1.52e-04 | 21 | 20 | 2 | CID000129283 | |
| Drug | AC1Q5T5H | 1.52e-04 | 21 | 20 | 2 | CID000005721 | |
| Drug | AC1L510Y | 1.68e-04 | 22 | 20 | 2 | CID000196040 | |
| Drug | Spotlight | 1.76e-04 | 126 | 20 | 3 | CID000086222 | |
| Drug | tryptophanyl-5'AMP | 1.83e-04 | 23 | 20 | 2 | CID000446202 | |
| Drug | chloranil | 2.00e-04 | 24 | 20 | 2 | CID000008371 | |
| Drug | DMAB | 2.07e-04 | 133 | 20 | 3 | CID000006053 | |
| Drug | 3-methyladenine | 2.11e-04 | 134 | 20 | 3 | CID000001673 | |
| Drug | baryta | 2.21e-04 | 136 | 20 | 3 | CID000062392 | |
| Drug | NSC71948 | 2.30e-04 | 138 | 20 | 3 | CID000415676 | |
| Drug | 2-nitroaniline | 2.35e-04 | 139 | 20 | 3 | CID000006946 | |
| Drug | glycine ethyl ester | 2.35e-04 | 26 | 20 | 2 | CID000012175 | |
| Drug | oxazole | 2.35e-04 | 26 | 20 | 2 | CID000009255 | |
| Drug | pentafluorobenzyl alcohol | 2.54e-04 | 27 | 20 | 2 | CID000009923 | |
| Drug | benzylamide | 2.54e-04 | 27 | 20 | 2 | CID000010391 | |
| Drug | C4:1n-2 | 2.73e-04 | 28 | 20 | 2 | CID000019499 | |
| Drug | Texas Red | 2.73e-04 | 28 | 20 | 2 | CID000452705 | |
| Drug | pyroantimonate | 2.73e-04 | 28 | 20 | 2 | CID006327644 | |
| Drug | 5(G)-TASP | 2.93e-04 | 29 | 20 | 2 | CID000488931 | |
| Drug | I-As | 3.43e-04 | 158 | 20 | 3 | CID000078017 | |
| Drug | AC1L1H88 | 3.58e-04 | 32 | 20 | 2 | CID000004018 | |
| Drug | II P | 3.58e-04 | 32 | 20 | 2 | CID000449430 | |
| Drug | chlorothalonil | 3.69e-04 | 162 | 20 | 3 | CID000015910 | |
| Drug | TG-3 | 3.81e-04 | 33 | 20 | 2 | CID000205489 | |
| Drug | CD367 | 3.81e-04 | 33 | 20 | 2 | CID000119342 | |
| Drug | AC1L1GZB | 4.03e-04 | 167 | 20 | 3 | CID000003908 | |
| Drug | 1pzj | 4.03e-04 | 167 | 20 | 3 | CID000447976 | |
| Drug | hypusine | 4.04e-04 | 34 | 20 | 2 | CID000065396 | |
| Drug | silver nanoparticles | 4.39e-04 | 172 | 20 | 3 | CID000023954 | |
| Drug | AC1L2U9H | 4.54e-04 | 36 | 20 | 2 | CID000077996 | |
| Drug | L-165041 | 4.54e-04 | 36 | 20 | 2 | CID006603901 | |
| Drug | phenylquinone | 4.54e-04 | 36 | 20 | 2 | CID000009688 | |
| Drug | Tripeptide derivative, 14 | 4.54e-04 | 36 | 20 | 2 | CID009918384 | |
| Drug | lithocholyltaurine | 4.62e-04 | 175 | 20 | 3 | CID000010595 | |
| Drug | KSCN | 4.79e-04 | 37 | 20 | 2 | CID000516872 | |
| Drug | Compound 10 | 4.79e-04 | 37 | 20 | 2 | CID003749170 | |
| Drug | 3-nitropropionic acid | 4.86e-04 | 178 | 20 | 3 | CID000001678 | |
| Drug | quinolinic acid | 4.94e-04 | 179 | 20 | 3 | CID000001066 | |
| Drug | resveratrol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.02e-04 | 180 | 20 | 3 | 958_UP | |
| Drug | cystamine | 5.10e-04 | 181 | 20 | 3 | CID000002915 | |
| Drug | liarozole | 5.33e-04 | 39 | 20 | 2 | CID000060652 | |
| Drug | CTK8G2960 | 5.52e-04 | 186 | 20 | 3 | CID005361912 | |
| Drug | p-phenylenediamine | 5.60e-04 | 40 | 20 | 2 | CID000007814 | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; HL60; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 1328_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 7417_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 6.15e-04 | 193 | 20 | 3 | 462_DN | |
| Drug | ManNAc-6-P | 6.18e-04 | 42 | 20 | 2 | CID000000898 | |
| Drug | glutamin | 6.21e-04 | 461 | 20 | 4 | CID000000738 | |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 6.24e-04 | 194 | 20 | 3 | 954_UP | |
| Drug | Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 5452_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 2895_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 2897_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 1532_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 3295_DN | |
| Drug | Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; HL60; HG-U133A | 6.33e-04 | 195 | 20 | 3 | 1573_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; HL60; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 2189_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 4980_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.33e-04 | 195 | 20 | 3 | 1045_UP | |
| Drug | Gleevec; Up 200; 10uM; MCF7; HG-U133A | 6.43e-04 | 196 | 20 | 3 | 366_UP | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 5407_UP | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 1867_UP | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 7424_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 2884_UP | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 2288_DN | |
| Drug | cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A | 6.43e-04 | 196 | 20 | 3 | 253_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4840_DN | |
| Disease | Cardiac Hypertrophy | 1.27e-03 | 82 | 19 | 2 | C1383860 | |
| Disease | Cardiomegaly | 1.27e-03 | 82 | 19 | 2 | C0018800 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.52e-03 | 90 | 19 | 2 | DOID:11832 (biomarker_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 4.53e-03 | 157 | 19 | 2 | DOID:224 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAAPMLRWGCRGRRW | 1 | O75879 | |
| GGFMRRVGRPEWWMD | 211 | P01210 | |
| WEQDGGRWLPGHCMA | 146 | P55042 | |
| VPGPWGRLCRDWDQM | 246 | O15528 | |
| MERKRWECPALPQGW | 1 | O95983 | |
| MAEDWLDCPALGPGW | 1 | Q9UIS9 | |
| PGGRGWASMLACRLW | 6 | Q13520 | |
| MGGLWRPGWRCVPFC | 1 | Q9Y6N1 | |
| PINPRLDGCMRSWNW | 436 | Q14393 | |
| KTRCWAQGMDGWRPL | 1006 | O75165 | |
| GNCRPGRWPVDAWEV | 101 | Q8TB03 | |
| HRMDQQCPRGWWGSP | 2021 | Q9NYQ7 | |
| RAAPGEPGWMGRLWV | 766 | O95180 | |
| MQDFWRRSCLGGWGP | 321 | A6NNN8 | |
| RGDMRECVWWVEPGA | 181 | Q01892 | |
| CWVESWMTRPDLQPG | 336 | P21980 | |
| PGSWCFLRMRWAQPG | 166 | P43119 | |
| RMGPRCAQALWRMPW | 11 | Q15904 | |
| MCWGKHWPRPEGRNL | 1 | Q6ZWC4 | |
| GRCWGWGRGMTRICP | 66 | Q8N9P0 | |
| CWMKRPDLPSGFDGW | 441 | P22735 | |
| PPMGWLAWERFRCNI | 26 | P17050 |